(S)-tert-butyl (1-(3-bromo-6-(3-hydroxy-3-methylazetidin-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate → (S)-1-(6-(1-amino-2-(3,5-difluorophenyl)ethyl)-5-bromopyridin-2-yl)-3-methylazetidin-3-ol
Reaktionsgleichung
[Br:1][C:2]1[C:3]([C@@H:14]([NH:24]C(=O)OC(C)(C)C)[CH2:15][C:16]2[CH:21]=[C:20]([F:22])[CH:19]=[C:18]([F:23])[CH:17]=2)=[N:4][C:5]([N:8]2[CH2:11][C:10]([OH:13])([CH3:12])[CH2:9]2)=[CH:6][CH:7]=1>C(O)(C(F)(F)F)=O.C(Cl)Cl>[NH2:24][C@H:14]([C:3]1[N:4]=[C:5]([N:8]2[CH2:11][C:10]([CH3:12])([OH:13])[CH2:9]2)[CH:6]=[CH:7][C:2]=1[Br:1])[CH2:15][C:16]1[CH:17]=[C:18]([F:23])[CH:19]=[C:20]([F:22])[CH:21]=1Komponenten
3
Edukt 1
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Compound 42G (64 mg, 0.13 mmol) was dissolved in 2 mL of 20% TFA/methylene chloride. The reaction mixture was stirred at room temperature for 2 hours and then partitioned between EtOAc and saturated aq. NaHCO3. The organic layer was separated and concentrated to afford the title product. MS (m/z) 398.03[M+H]+.